David Olmos Selected Research

Taxoids (Taxanes)

5/2021	Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients.
1/2021	Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Olmos Research Topics

Disease

51	Prostatic Neoplasms (Prostate Cancer) 03/2022 - 04/2009
34	Neoplasms (Cancer) 01/2022 - 12/2005
13	Neoplasm Metastasis (Metastasis) 03/2022 - 04/2009
7	Fatigue 01/2020 - 03/2010
7	Nausea 01/2020 - 03/2010
6	Circulating Neoplastic Cells 05/2021 - 04/2009
6	Exanthema (Rash) 01/2021 - 12/2011
5	Vomiting 02/2014 - 02/2010
5	Sarcoma (Soft Tissue Sarcoma) 01/2013 - 02/2010
4	Disease Progression 12/2020 - 08/2009
3	Carcinogenesis 09/2016 - 09/2011
3	Hodgkin Disease (Hodgkin's Disease) 05/2015 - 03/2006
3	Diarrhea 02/2015 - 12/2011
3	Hyperglycemia 11/2014 - 03/2010
3	Ewing Sarcoma (Sarcoma, Ewing) 01/2011 - 02/2010
2	Rhabdomyosarcoma 01/2017 - 01/2011
2	Stomatitis 02/2015 - 12/2011
2	Pruritus (Itching) 04/2013 - 12/2011
2	Colorectal Neoplasms (Colorectal Cancer) 12/2011 - 01/2009
1	Sepsis (Septicemia) 01/2022
1	Pneumonia (Pneumonitis) 10/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2021
1	Myocardial Infarction 10/2021
1	Microsatellite Instability 01/2021
1	Weight Loss (Weight Reduction) 01/2020
1	Frailty 01/2020
1	Pain (Aches) 01/2020
1	Arthralgia (Joint Pain) 01/2020
1	Anemia 01/2020
1	Hypothyroidism 04/2018
1	Carcinoma (Carcinomatosis) 11/2015

Drug/Important Bio-Agent (IBA)

16	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2011
9	enzalutamideIBA 03/2022 - 01/2019
9	apalutamideIBA 03/2022 - 04/2018
9	abirateroneIBA 12/2021 - 10/2018
8	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 09/2016
8	Docetaxel (Taxotere)FDA Link 12/2021 - 03/2010
7	AndrogensIBA 03/2022 - 04/2009
7	Androgen Receptors (Androgen Receptor)IBA 10/2021 - 04/2018
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2011
6	Hormones (Hormone)IBA 10/2021 - 04/2009
6	Abiraterone AcetateIBA 09/2021 - 04/2009
6	Pharmaceutical PreparationsIBA 08/2014 - 05/2011
6	Insulin-Like PeptidesIBA 09/2011 - 02/2010
5	Prostate-Specific Antigen (Semenogelase)IBA 02/2022 - 04/2009
4	taxaneIBA 01/2022 - 01/2019
4	olaparibIBA 01/2022 - 01/2020
4	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022 - 09/2016
4	Monoclonal AntibodiesIBA 04/2013 - 03/2010
3	PlatinumIBA 01/2021 - 01/2017
3	Biological ProductsIBA 01/2017 - 05/2010
3	MK 2206IBA 02/2015 - 12/2011
3	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 03/2010 - 06/2009
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	niraparibIBA 01/2022 - 09/2021
2	ipatasertibIBA 10/2021 - 09/2021
2	cabazitaxel FDA Link 09/2021 - 01/2019
2	Radium-223IBA 09/2021 - 09/2017
2	Taxoids (Taxanes)IBA 05/2021 - 01/2021
2	Prednisone (Sone)FDA LinkGeneric 12/2020 - 10/2018
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2018 - 08/2009
2	PolyaminesIBA 01/2018 - 01/2017
2	Cell-Free Nucleic AcidsIBA 01/2018 - 12/2011
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2017 - 04/2016
2	EnzymesIBA 05/2015 - 10/2013
2	LigandsIBA 04/2013 - 03/2010
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2012 - 06/2009
2	AlbuminsIBA 03/2012 - 06/2009
2	Insulin (Novolin)FDA Link 12/2011 - 05/2010
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 03/2010 - 02/2010
2	figitumumabIBA 03/2010 - 02/2010
1	darolutamideIBA 03/2022
1	Androgen Antagonists (Antiandrogens)IBA 03/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 10/2021
1	talazoparibIBA 09/2021
1	rucaparibIBA 09/2021
1	Phenobarbital (Luminal)FDA Link 07/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	pembrolizumabIBA 01/2021
1	Poly Adenosine Diphosphate RiboseIBA 01/2020
1	SteroidsIBA 10/2018
1	MicroRNAs (MicroRNA)IBA 01/2017
1	S-adenosyl-3-methylthiopropylamineIBA 01/2017
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 09/2016
1	Mechanistic Target of Rapamycin Complex 2IBA 04/2016
1	OSI 027IBA 04/2016
1	Vascular Endothelial Growth Factor CIBA 05/2015
1	ImmunosorbentsIBA 05/2015
1	AZD 6244IBA 02/2015
1	Lipase (Acid Lipase)FDA Link 02/2015

Therapy/Procedure

41	Castration 03/2022 - 04/2009
24	Therapeutics 03/2022 - 01/2009
9	Drug Therapy (Chemotherapy) 09/2021 - 03/2006
3	Radiotherapy 09/2021 - 08/2015
2	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 08/2015
2	Aftercare (After-Treatment) 01/2020 - 08/2015
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021
1	Infant Equipment (Crib) 01/2021